Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say
HAEHaemonetics(HAE) Zacks Investment Research·2024-05-09 22:36

For the quarter ended March 2024, Haemonetics (HAE) reported revenue of 343.29million,up12.8343.29 million, up 12.8% over the same period last year. EPS came in at 0.90, compared to 0.77intheyear−agoquarter.ThereportedrevenuecomparestotheZacksConsensusEstimateof0.77 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of 326.95 million, representing a surprise of +5.00%. The company delivered an EPS surprise of +2.27%, with the consensus EPS estimate being $0.88. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...